edgen-logoBeta

Chat with Ed

Invest

Brief

Desk
Others

News

Discover

Portfolio
Missions
Follow our

Join our

EN
Back


healthcare: pharmaNews

For youMarketsEconomyTech & AICryptoEnergyHealthcareHK & ChinaFinance

Pharma

Biotech

Health Services

Medical Devices

AbbVie adds $43B in market cap as acquisitions and approvals drive rally

AbbVie adds $43B in market cap as acquisitions and approvals drive rally

Jun 30 2026, 17:59
BeOne Medicines BRUKINSA cuts MCL progression risk by 43% in Phase 3

BeOne Medicines BRUKINSA cuts MCL progression risk by 43% in Phase 3

Jun 30 2026, 10:28
Medicare covers GLP-1 weight loss drugs at $50 copay starting July 1

Medicare covers GLP-1 weight loss drugs at $50 copay starting July 1

Jun 30 2026, 09:26
Arcutis wins FDA approval for Zoryve cream in children as young as 2

Arcutis wins FDA approval for Zoryve cream in children as young as 2

Jun 29 2026, 23:24
FDA picks 7 drugmakers for pilot to speed factory reviews

FDA picks 7 drugmakers for pilot to speed factory reviews

Jun 29 2026, 19:25
J&J's Tecvayli combo cuts myeloma progression risk by 83.4%

J&J's Tecvayli combo cuts myeloma progression risk by 83.4%

Jun 29 2026, 16:58
Novo Nordisk's 54.6% GLP-1 share tops Viking's obesity drug challenge

Novo Nordisk's 54.6% GLP-1 share tops Viking's obesity drug challenge

Jun 29 2026, 16:28
NeuroSense hits Phase 2b ALS goal with TDP-43 reduction, plans Phase 3

NeuroSense hits Phase 2b ALS goal with TDP-43 reduction, plans Phase 3

Jun 29 2026, 13:53
Eli Lilly rises 2% pre-market after positive Phase 3 trial data

Eli Lilly rises 2% pre-market after positive Phase 3 trial data

Jun 29 2026, 12:19
Biohaven begins Phase 3 trial of first-in-class Graves' drug BHV-1300

Biohaven begins Phase 3 trial of first-in-class Graves' drug BHV-1300

Jun 29 2026, 11:59
Sandoz wins FDA review for 2 generic tirzepatide GLP-1s

Sandoz wins FDA review for 2 generic tirzepatide GLP-1s

Jun 29 2026, 09:58
Novo Nordisk Wegovy pill hits 152,000 scripts as oral GLP-1 race heats up

Novo Nordisk Wegovy pill hits 152,000 scripts as oral GLP-1 race heats up

Jun 29 2026, 09:24
AbbVie's upadacitinib secures positive CHMP opinion for vitiligo, first systemic option

AbbVie's upadacitinib secures positive CHMP opinion for vitiligo, first systemic option

Jun 29 2026, 08:21
Pfizer, Innovent win preliminary nod for 2 GLP-1 drugs in China

Pfizer, Innovent win preliminary nod for 2 GLP-1 drugs in China

Jun 29 2026, 05:53
Medicare to cover obesity drugs at $50 copay starting July 1

Medicare to cover obesity drugs at $50 copay starting July 1

Jun 28 2026, 12:24
Eli Lilly surges 7.5% as weight loss drugs, cancer pipeline drive gains

Eli Lilly surges 7.5% as weight loss drugs, cancer pipeline drive gains

Jun 27 2026, 00:57
FDA approves Viridian's Lumvoa for thyroid eye disease in 2 trials

FDA approves Viridian's Lumvoa for thyroid eye disease in 2 trials

Jun 26 2026, 22:28
Lantheus receives FDA CRL for NET imaging drug LNTH-2501

Lantheus receives FDA CRL for NET imaging drug LNTH-2501

Jun 26 2026, 20:23
Acadia Pharma jumps 12% as EU panel reverses course on Rett drug

Acadia Pharma jumps 12% as EU panel reverses course on Rett drug

Jun 26 2026, 18:26
GLP-1 pill launches risk 2027 employer coverage cuts for 1 in 10 plans

GLP-1 pill launches risk 2027 employer coverage cuts for 1 in 10 plans

Jun 26 2026, 14:54

Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Crypto Comparison
Home Page
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
Terms of UsePrivacy PolicySitemap
© 2026 Edgen Powered byedgen-logo